Publication | Closed Access

Simultaneous analysis of anticancer agents bortezomib, imatinib, nilotinib, dasatinib, erlotinib, lapatinib, sorafenib, sunitinib and vandetanib in human plasma using LC/MS/MS

Medicinal ChemistryOncologyMedicineAnticancer Agents BortezomibHuman PlasmaSimultaneous AnalysisPharmacotherapyAnti-cancer AgentCancer TreatmentPharmacologyRadiation OncologyCancer ResearchDrug DiscoveryDrug Analysis